Opendata, web and dolomites

MOsteoDD

PLATFORM FOR THE FRONTLINE OF OSTEOPOROSIS PREVENTION

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MOsteoDD project word cloud

Explore the words cloud of the MOsteoDD project. It provides you a very rough idea of what is the project "MOsteoDD" about.

doctor    customer    population    diagnosed    fractures    data    women    worth    efficient    billion    report    direct    written    ict    frontline    composition    issued    first    smei    36bn    scanning    mark    9bn    burden    pace    broken    mosteodd    wroclaw    dexa    citizens    tools    europ    spectroscopy    maturing    conformit    attributed    clinical    generate    trl    device    validation    doctors    seeking    bones    prevent    aging    detection    osteoporosis    service       painless    elderly    poland    flags    bonevitae    web    diagnosis    95    platform    76    serve    diagnostics    opportunity    readiness    seconds    version    minimum    bone    enter    medical    enne    prevention    powerful    time    2050    invasive    annual    mvp    eacute    impedance    screening    vitae    fast    efforts    globally    setup    mission    health    stage    venture    bio    pl    diagnostic    prescriptions    union    chemical    directed    start    output    provides    patented    electrode    patients    small    ce    accuracy    innovative    osteoscanner    company    core    reducing    onset    six    market    care   

Project "MOsteoDD" data sheet

The following table provides information about the project.

Coordinator
BONE VITAE SPOLKA AKCYJNA 

Organization address
address: MUCHOBORSKA, NR 18
city: WROCLAW
postcode: 54 424
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Project website http://www.bonevitae.pl/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-07-01   to  2016-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BONE VITAE SPOLKA AKCYJNA PL (WROCLAW) coordinator 50˙000.00

Map

 Project objective

Osteoporosis is the most common reason for broken bones among elderly women. In the European Union, annual direct medical costs of fractures attributed to osteoporosis reach €36bn and are expected to rise to €76.9bn by 2050 in pace with the aging of population. Early diagnosis and prevention is the key to reducing this burden and deliver more efficient health care to European citizens with new tools for doctors to better serve their patients. Our mission at BONE VITAE (www.bonevitae.pl, Wroclaw, Poland) is to implement fast in-practice medical screening for early flags of osteoporosis with our patented osteoscanner ICT platform, the new frontline of prevention. Our non-invasive and painless bio-impedance spectroscopy technology is the only one that provides data on bone composition and chemical changes that mark the very start of osteoporosis onset, when there is still time to prevent it. The Multi-electrode Osteoporosis Detection Device (MOsteoDD) platform is an exciting market opportunity for our company, a small, highly innovative venture with a powerful patented core technology seeking to enter the growth market of osteoporosis diagnostics worth $6–7 billion a year globally. Our patented six-electrode setup provides 95% diagnostic accuracy results in less than 40 seconds, while the platform’s web service will analyse the device output and generate a written report for doctor’s use allowing pre-diagnosed patients to be referred for further scanning (DEXA) or for prescriptions to be issued. The first version of the MOsteoDD osteoscanner has clinical validation in Poland and the CE mark (Conformité Européenne), and is currently at Minimum Viable Product (MVP) stage at Technology Readiness Level (TRL) 8. Current efforts are directed at maturing the platform to specific customer needs to reach the market with the support of SMEI funding.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOSTEODD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOSTEODD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More